Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) Interest & Investment Income (2009 - 2026)

Updated

Immucell's Interest & Investment Income was $69,960 in Q3 2026, up 68.7% from $41,468 a year earlier and up 7.1% from the prior quarter.

Analysis

Immucell (ICCC) Interest & Investment Income (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Immucell's Interest & Investment Income was $211,329 through Sep 30, 2026, up 29.4% year-over-year; for FY2025, it came in at $158,709, up 104.3% from FY2024.

  • Interest & Investment Income shows a three-year compound annual growth rate of 1.2% (FY2022 to FY2025).
  • In earlier years, Interest & Investment Income was $77,702 in FY2024 (-19.5%), $96,570 in FY2023 (-36.9%) and $153,100 in FY2022.
  • The Q3 2026 figure marks the highest quarterly Interest & Investment Income in data going back to Q1 2009.
  • Compared with a year earlier, Interest & Investment Income has increased for three straight quarters, with growth averaging 112.6% over the last seven quarters.
  • The best year-over-year quarter for Interest & Investment Income over five years was Q1 2025 (growth of 293.3%); the worst was Q1 2024 (a decline of 76.6%).
  • Per Business Quant data, ICCC's Interest & Investment Income in the three quarters before Q3 2026 was $65,343 (Q2 2026), $44,367 (Q1 2026) and $31,659 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 186.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 67.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn 69,960.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 69,960.00
Jun 30, 2026 65,343.00
Mar 31, 2026 44,367.00
Dec 31, 2025 31,659.00
Sep 30, 2025 41,468.00
Jun 30, 2025 48,113.00
Mar 31, 2025 37,469.00
Dec 31, 2024 36,226.00
Sep 30, 2024 18,685.00
Jun 30, 2024 13,264.00
Mar 31, 2024 9,527.00
Jun 30, 2023 14,806.00
Mar 31, 2023 40,631.00
Dec 31, 2019 27,150.00
Sep 30, 2019 41,719.00
Jun 30, 2019 47,099.00
Mar 31, 2019 2,315.00
Dec 31, 2018 4,031.00
Sep 30, 2018 3,237.00
Jun 30, 2018 3,209.00
API Access

Immucell Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ICCC&period=max&api_key=YOUR_API_KEY